Search
Now showing items 1-10 of 14
Safety and immunogenicity of DNA and MVA HIVA vaccines in Phase-1 vaccine trials in Nairobi, Kenya
(University of Nairobi, 2004)
Reasons for declining enrolment among eligible volunteers in a phase II HIV vaccine trial in Kenya
(University of Nairobi, 2004)
Safety Issues, DNA & MVA HIV Vaccine Trials at KAVI Oral presentation
(University of Nairobi, 2003-01)
The Use of Viral Peptides as a Quality Control for ELISPOT Assays in HIV-1 Vaccine Trials in Kenya
(University of Nairobi,, 2004)
Abstract no. A10065"
CD4+ and CD8+lymphocyte distribution among healthy Kenyans
(University of Nairobi, 2004)